n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, October 1st, 2015

The QualityStocks
Daily Stock List

graphic
graphic

Vape Holdings, Inc. (VAPE)

Money Morning, TheMicrocapNews, Real Pennies, Shiznit Stocks and Greenbackers reported on Vape Holdings, Inc. (VAPE), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Chatsworth, California-based Vape Holdings, Inc. concentrates on designing, marketing, and distributing various vaporization products. The Company also provides management, consulting, branding, real estate and compliant packaging solutions to lawfully operating participants in the legal cannabis industry. Vape Holdings’ shares trade on the OTC Markets Group’s OTCQB.

Vape offers medical and food grade ceramic products chiefly under the HIVE Ceramics brand throughout North America, Europe and South America. HIVE offers a nonporous, non-corrosive, chemically inert ceramic vaporization element. It can be used for a range of applications. This includes stand-alone vaporization products and electronic cigarettes.

Vape Holdings has created Offset, LLC for branding, marketing and merchandising services. Moreover, Vape is positioned to provide additional services and solutions in the legal cannabis industry.

In August, Vape Holdings announced it executed a collaboration agreement with Puffco for a new portable vaporizer pen. The expectation is that the vaporizer pen, with Vape’s HIVE ceramic atomizer, will be available by December 2015. Recently, the Puffco Pro was named Best Vaporizer of 2015 by High Times Magazine. The Puffco Pro has a protective UV coating and a custom designed ceramic chamber. The Puffco Pro has no glues, no plastics and no fibers. It leads the industry by having the largest ceramic chamber.

In addition, in August, VAPE Holdings announced the filing of its 10Q quarterly report and quarterly results for its fiscal Q3 ended June 30, 2015. For the three months ended June 30, 2015 and 2014, revenue was $282,331 and $361,781, respectively. Revenue was more in 2014 because it was HIVE Ceramics' first full revenue-generating quarter following the launch of its full product line. Nevertheless, in 2015, Vape Holdings now receives its revenue from the sale of ceramics, supplies, glass, merchandise, and services. For the nine months ended June 30, 2015 and 2014, revenue was $1,084,233 and $392,540, respectively.

For the three months ended June 30, 2015 and 2014, net loss was $436,052 and $1,358,587, respectively. For the nine months ended June 30, 2015 and 2014, net income and loss was $232,002 and ($31,163,151), respectively.

Vape Holdings, Inc. (VAPE), closed Thursday's trading session at $0.034, down 12.82%, on 1,602,843 volume with 129 trades. The average volume for the last 60 days is 332,208 and the stock's 52-week low/high is $0.027/$2.09.

Premier Holding Corp. (PRHL)

SmallCapVoice, The Green Baron, and Clutch Investments reported on Premier Holding Corp. (PRHL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Premier Holding Corp. is an energy holding company centering on acquiring and integrating energy companies as synergistic subsidiaries. Premier accumulates residential and commercial clients in deregulated markets from all subsidiaries and cross sells energy and energy efficiency products and services, maximizing profit potential and minimizing cost of client procurement. Premier Holding is based in Tustin, California.

The Company, via its subsidiaries, offers renewable energy production, energy efficiency products and services to commercial middle-market companies, Fortune 500 brands, developers, and management companies of large-scale residential developments. Premier’s companies lower its clients’ price and usage of energy. Its subsidiary, The Power Company (TPC), through deregulated energy expertise, has helped tens of thousands of clients.

Through its energy efficiency company, E3 - Energy Efficiency Experts, Premier allows for ongoing support through energy management and information systems. Premier Holding’s additional integrated business offerings include direct energy services as Power Purchase Agreements (PPAs), energy financing and leasing of generation programs in urban and rural real estate environments, lighting efficiency systems, and refrigeration systems.

Premier continues to explore opportunities to become a supplier through application or acquisition/merger with an existing supplier to fulfill its plans for growth. Once completed, the new subsidiary will be a power provider/supplier licensed with the Public Utility Commissions. This subsidiary will enable Premier to take advantage of the marketing success of energy brokers such as The Power Company and ultimately create new energy efficiency prospects for E3, enabling Premier to further its plan of integration in this sector.

Premier Holding has acquired 85 percent of Lexington Power and Light, LLC (LP&L) and operates now as a supplier of energy (electricity and natural gas) in deregulated markets. The purchase of Lexington Power and Light is an integral part of Premier’s larger plan to provide "everything energy" to its thousands of clients and the large potential energy market.

In July 2015, Premier Holding, the parent company of an ESCO, an energy seller, and a reseller in deregulated markets, announced that its subsidiary Energy Efficiency Experts (E3) was appointed by Kaiser Foundation Hospitals as a preferred vendor to perform LED retrofits for their facilities across the nation. E3 starts this relationship with their flagship hospital in Anaheim for interior lighting and has also been chosen for the Santa Ana Medical Office Building parking lot project.

Premier Holding Corp. (PRHL), closed Thursday's trading session at $0.07, up 4.48%, on 100 volume with 1 trade. The average volume for the last 60 days is 33,482 and the stock's 52-week low/high is $0.022/$0.11.

Soligenix, Inc. (SNGX)

OTC Markets Group, PennyStocks24, Pennybuster, Streetwise Reports, and InvestorPlace reported earlier on Soligenix, Inc. (SNGX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Soligenix, Inc. is a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology, and biodefense. Its proprietary vaccine thermostabilization technology is ThermoVax™.  The Company’s areas of focus include a therapeutics segment devoted to the development of products for orphan diseases and areas of unmet medical need. This includes cutaneous T-cell lymphoma, oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and Graft-versus-Host disease (GVHD). Soligenix is based in Princeton, New Jersey.

Its second area of focus is a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis. Soligenix is developing proprietary formulations of oral BDP (beclomethasone 17,21-dipropionate) for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation. This includes pediatric Crohn's disease (SGX203) and acute radiation enteritis (SGX201).

Additionally, Soligenix is advancing its novel innate defense regulator (IDR) technology SGX942 for the treatment of oral mucositis and SGX301, its novel first-in-class photodynamic technology using synthetic hypericin with safe visible light, for the treatment of cutaneous T-cell lymphoma.

Its biodefense products in development include a recombinant subunit vaccine named RiVax™. The design of it is to protect against the lethal effects of exposure to ricin toxin. RiVax™ has been granted orphan drug designation by the Food and Drug Administration (FDA) for the prevention of ricin intoxication.

Moreover, the Company is developing VeloThrax™, a vaccine against anthrax exposure. Soligenix is also developing OrbeShield™ for the treatment of gastrointestinal acute radiation syndrome (GI ARS) under a BARDA (Biomedical Advanced Research and Development Authority) contract award. Soligenix also has an exclusive worldwide collaboration with Intrexon Corp. (XON). The emphasis of it is on the joint development of a treatment for Melioidosis, a high priority biothreat and an area of unmet medical need.

Soligenix will be working with the National Organization for Rare Disorders (NORD) and the Cutaneous Lymphoma Foundation (CLF) to educate and recruit patients for its pivotal Phase 3 clinical study of SGX301 (synthetic hypericin) in the treatment of cutaneous T-cell lymphoma (CTCL). SGX301 has previously been granted orphan drug and fast track designations from the FDA for the first-line treatment of CTCL, a rare disease and a class of non-Hodgkin's lymphoma, a kind of cancer of the white blood cells that are an essential element of the immune system.

At the end of August, Soligenix announced it completed enrollment of the additional subjects, as directed by the Data Review Committee (DRC) earlier in 2015, into its Phase 2 study for SGX942.  SGX942 is a first-in-class innate defense regulator (IDR). It is undergoing evaluation as a treatment for oral mucositis in patients undergoing chemoradiation (CRT) therapy for head and neck cancer.  Soligenix anticipates reporting preliminary results in Q4 2015. 

Soligenix, Inc. (SNGX), closed Thursday's trading session at $1.01575, down 5.07%, on 107,107 volume with 92 trades. The average volume for the last 60 days is 148,008 and the stock's 52-week low/high is $0.91/$2.95.

Symbid Corp. (SBID)

We are highlighting Symbid Corp. (SBID) today, here at the QualityStocks Daily Newsletter.

Founded in 2011, Symbid Corp., in essence, is The Funding Network™, where companies get funding and grow. Symbid (www.symbid.com) is a leading online funding site for small- and medium-sized enterprises. Symbid gives entrepreneurs direct access to traditional and alternative forms of finance. It does so offering investors full transparency on the potential risks and returns of their portfolio. Symbid began as one of the first equity crowdfunding platforms worldwide. Symbid has its corporate headquarters in Rotterdam, the Netherlands. The Company’s shares trade on the OTC Bulletin Board.

The Funding Network™ provides advanced investing, monitoring and data tools. It is built around pioneering technology and expert financial advice. The Funding Network™ by Symbid is a platform for entrepreneurs looking for funding and investors in search of opportunities. The Funding Network™ has to date guided more than 400 small businesses to greater than $330 million in funding from alternative and traditional sources. This includes equity and loan crowdfunding, bank loans, venture capital and angel investors.

Symbid announced this year that the Company received the Dutch FinTech Award for SME Finance following the launch of The Funding Network™ in March 2015. More than 100 companies were funded through The Funding Network™ in less than two months for a total of $68.5 million. This award is recognition of Symbid's dedication to simplifying the way small businesses are funded through innovative financial technology. Co-founder and CCO Robin Slakhorst collected the award on behalf of Symbid.

This past June, Symbid announced the launch of its own loan crowdfunding product. The launch means Symbid now offers equity and loan crowdfunding in addition to traditional and other alternative funding options by way of The Funding Network™. This includes angel investing, venture capital as well as bank loans.

In September, Symbid announced a strategic partnership with DNOB, the new funding platform for entrepreneurs led by Hans Biesheuvel, former Chairman of MKB Nederland (Dutch SME Trade Association). DNOB will connect to The Funding Network™, operated by Symbid. DNOB will connect entrepreneurs to business financing.

Symbid Corp. (SBID), closed Thursday's trading session at $0.30, down 6.25%, on 15,010 volume with 5 trades. The average volume for the last 60 days is 10,879 and the stock's 52-week low/high is $0.10/$0.75.

Arno Therapeutics, Inc. (ARNI)

Streetwise Reports and SmallCapVoice reported on Arno Therapeutics, Inc. (ARNI), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

Arno Therapeutics, Inc. is a clinical stage biopharmaceutical company listed on the OTCQB. The Company mainly concentrates on the development of therapeutics for the treatment of cancer and other life threatening diseases. It has exclusive global rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors, and also infectious diseases. The Company is headquartered in Flemington, New Jersey.

Arno Therapeutics’ product pipeline includes Onapristone, AR-42, and AR-12. Onapristone is a progesterone receptor antagonist. It has demonstrated anti-tumor activity in preclinical and clinical studies of hormone-dependent tumors. AR-42 is a novel, oral agent therapy now in early clinical development. AR-12 is an orally-available small molecule.

Concerning AR-12, preliminary data demonstrate that the mechanism of action may include induction of host cell autophagy and inhibition of fungal acetyl coenzyme A synthetase. Earlier, AR-12 completed Phase 1 clinical trials in patients with cancer. Additional pre-clinical research indicates that AR-12 may have potential as an antimicrobial agent in different infectious diseases.

Arno Therapeutics announced in 2015 that the European Commission, acting on the recommendation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA), designated AR-12 as an orphan medicinal product for the treatment of two separate infectious diseases, cryptococcosis and tularaemia. The European Commission grants orphan designations for medicines that treat a life-threatening or chronically debilitating condition affecting no greater than five in 10,000 persons in the EU and where no satisfactory treatment is available.

Last week, Arno Therapeutics announced data from a preclinical study demonstrating AR-13, an analogue of its AR-12 infectious disease compound portfolio, has promise as a potential new therapeutic option for patients with cystic fibrosis (CF) acutely and chronically infected with Burkholderia cenocepacia and other antibiotic resistant organisms, including Pseudomonas aeruginosa. The presentation of the dataset will be in a poster session during the upcoming 29th Annual North American Cystic Fibrosis (NACF) Conference, taking place October 8-10, 2015 in Phoenix, Arizona.

Additionally, last week, Arno Therapeutics announced that a late-breaking abstract on AR-12 was accepted for poster presentation at the upcoming 15th European AIDS Conference, hosted by the European AIDS Clinical Society (EACS) and taking place October 21-24, 2015 in Barcelona, Spain.

Arno Therapeutics, Inc. (ARNI), closed Thursday's trading session at $0.35, even for the day, on 112,975 volume with 12 trades. The average volume for the last 60 days is 17,743 and the stock's 52-week low/high is $0.21/$1.33.

graphic

The QualityStocks
Company Corner

graphic
graphic

Hemp, Inc. (HEMP)

The QualityStocks Daily Newsletter would like to spotlight Hemp, Inc. (HEMP). Today, Hemp, Inc. closed trading at $0.053, up 1.92%, on 2,257,456 volume with 182 trades. The stock’s average daily volume over the past 60 days is 828,435, and its 52-week low/high is $0.049/$1.00.

Hemp, Inc. announced today Senate Bill 313 passed the House on September 28, 2015 (with a vote of 101 to 7) and the Senate on September 29, 2015 (with a vote of 42 to 2) in favor of the proposed Industrial Hemp legislation in North Carolina. According to the North Carolina Industrial Hemp Association (NCIHA), "this legislation will authorize an industrial hemp pilot program within the state of North Carolina and establish the Industrial Hemp Commission (IHC) to be followed by pilot program participants." IHC will implement the university research program.

Hemp, Inc. (HEMP) is engaged in the research and development of all things made of industrial hemp. From fabric, paper, cosmetics, food and jewelry to pulp, fuel, paints and more, the application of hemp represents a myriad of possibilities. The company strategizes to recognize the profits that could be made in making the world a better place through the industrial commercialization of this resource.

Hemp, Inc. subsidiaries include Industrial Hemp Manufacturing, LLC, which will soon be offering DrillWall™ for maintaining the seals on drilling for water, oil, gas and any other liquid or gas; and The Industrial Hemp and Medical Marijuana Consulting Company, Inc., which pulls pertinent market information from a vast network of professionals, specialists and experts from various niches of the hemp industry.

Las Vegas-based Hemp, Inc. conducts its operations through its 70,000-square-foot processing plant and decortication line of equipment, which is useful manufacturing more than 50,000 commercial products. The company's current line of offerings include hemp-infused body candles, shampoo and conditioner, smoothies, jewelry, healing oils, twine, lip balm and skin moisturizers.

Hemp products are used all over America every day and are sold in the largest and most respected stores. Not to be confused with marijuana, hemp does not contain psychoactive compounds and is legal in the United States and most of the world. Hemp, Inc.'s mission is to educate the public on this important differentiation while working to expand corporate infrastructure and invest in profitable, legal and diversified ventures poised to bring reward and value to shareholders. Disclaimer

Hemp, Inc. Company Blog

Hemp, Inc. News:

North Carolina House and Senate Pass Industrial Hemp Bill

GAWK Customer Win HEMP, Inc. (OTC PINK: HEMP)

Hemp Bill Puts Industrial Hemp One Step Closer to Legalization in North Carolina

On the Move Systems, Inc. (OMVS)

The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $0.67, even for the day, on 57,740 volume with 61 trades. The stock’s average daily volume over the past 60 days is 85,132, and its 52-week low/high is $0.2501/$11.04.

On the Move Systems, Inc. reports it is in preliminary discussions with an innovative freight-booking technology company for a potential joint venture project that could revolutionize the way truckers and shippers do business. If consummated, the joint venture would bring together companies that have already made a strong mark in their ends of the logistics industry.

On the Move Systems, Inc. (OMVS) specializes in the development of cutting-edge technology to transform and synchronize freight supply chain operations for a broad range of industries. The company is exploring new online tools to reduce costs and increase convenience in the tourism and travel industry, as well as new opportunities in trucking. OMVS works with a premier group of international providers to offer its services in two key divisions: Trucking Logistics and Inter-modal Freight.

Logistics are critical to the success of any operation. OMVS's Trucking Logistics division operates as one of the most competitive, full-service transportation logistics providers in the United States. Utilizing the company's ISTx Platform, this division helps customers strategize how to get from one point to another, as well as solves some of the toughest logistics challenges on the road today. OMVS's Trucking Logistics technology provides customers increased visibility, minimal-cost route effectiveness, and delivery assurance.

OMVS's Intermodal Freight division offers seamless cargo continuation, tracking, shipping and receiving of goods anywhere in the world. The company's customer service teams and drivers communicate through the ISTx Platform allowing for flexibility, control and monitoring of each freight shipment. OMVS continues to research and explore the most effective and resourceful tools in order to effectively serve customers with unique shipping requirements in the billion dollar trucking industry.

In his more than 20 years of experience, OMVS president and CEO Robert Wilson has cultivated vast expertise as an executive and financial consultant for companies in aviation, energy, oil and gas, IT and healthcare. In addition to his work valuing and assessing small-to-middle market companies, Wilson has also served as both an officer and director of such client companies. Wilson applies his expertise in the transportation business and investment banking to spearhead OMVS's new initiative to create a new kind of online transportation platform to an international market Disclaimer

On the Move Systems, Inc. Company Blog

On the Move Systems, Inc. News:

OMVS in Joint Venture Talks with Online Freight Brokerage Developer

OMVS Searching for Potential Joint Venture Partners as Shared Economy App Nears Launch

OMVS: Coming Capacity Shortage Opens Opportunity for Shared Economy Trucking App

Cherubim Interests, Inc. (CHIT)

The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.0082, up 262.83%, on 26,621,808 volume with 520 trades. The stock’s average daily volume over the past 60 days is 1,545,660, and its 52-week low/high is $0.0016/$0.5535.

Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.

The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.

Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.

Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer

Cherubim Interests, Inc. Company Blog

Cherubim Interests, Inc. News:

Cherubim Interests, Inc. Introduces New Corporate Website to Better Showcase Operations, Updates

Cherubim Interests, Inc. (CHIT) Announces Engagement of QualityStocks Investor Relations Services

Cherubim Interests Inc. Acquires License to Enter Controlled Environment Agriculture Industry

Latitude 360, Inc. (LATX)

The QualityStocks Daily Newsletter would like to spotlight Latitude 360, Inc. (LATX). Today, Latitude 360, Inc. closed trading at $0.0411, up 33.01%, on 2,115,633 volume with 91 trades. The stock’s average daily volume over the past 60 days is 226,416, and its 52-week low/high is $0.0215/$1.655.

Latitude 360, Inc. (LATX) is an award-winning pioneer of a dining and entertainment venues that combine premier upscale casual dining with numerous state-of-the-art entertainment choices. The company develops, constructs and operates cutting-edge Latitude 360 venues ranging from 35,000-85,000 sq. ft., packed full of eating and entertainment options that appeal to a broad base of guests, private events and corporate clients.

Through its three current award-winning locations in Jacksonville, Florida, Pittsburgh, Pennsylvania, and Indianapolis, Indiana, Latitude 360 employs roughly 500 talented individuals working to deliver the brand's unique "360 EXPERIENCE" which fuses the magic of exceptional food and beverage with multiple entertainment options in upscale, contemporary-designed venues. Key offerings at each 360 location include Las Vegas-style live performance showroom, a feature bar featuring the area's top musicians and/or DJs, luxury bowling, dine-in movies, high-definition sports theatre, game arcade and luxury cigar lounge and many choices of private meeting space.

In 2014 Latitude 360 launched the first-of-its-kind monthly club membership program which provides guests with a cache of monthly entertainment assets at a value price as well as exclusive access to a 360 Club Concierge service – all for a monthly fee. The program has quickly grown to more than 5,000 monthly paying members.

Latitude 360 recently expanded its entertainment offerings when it acquired Major League Fantasy (MLF), a leader in the daily fantasy sports industry. By implementing "360 Fantasy Live" into is existing locations, Latitude 360 is making a strong entrance into a rapidly growing market expected to reach $6 billion-$10 billion by year-end 2016. The acquisition of MLF allows Latitude 360 to position itself as one of the first live, multimedia venues to offer in-house, high-stakes, competitive daily fantasy events.

Led by an experienced and visionary management team, Latitude 360 is focused on further expanding its brick and mortar locations and anticipates opening additional 360 venues overseas and domestically in major cities like New York, Boston, Atlantic City and Chicago. Disclaimer

Latitude 360, Inc. Company Blog

Latitude 360, Inc. News:

Multi-Dimensional Entertainment Eatery Latitude 360 Enhances Guest Experience and Engagement Through Partnership With MyCheck

NFL Week One Contests Now Available on 360 Fantasy Live.com

Latitude 360 Officially Launches "360 Fantasy Live"

Giggles N' Hugs, Inc. (GIGL)

The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.17505, up 9.41%, on 17,600 volume with 4 trades. The stock’s average daily volume over the past 60 days is 23,860, and its 52-week low/high is $0.101/$0.55.

Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.

In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.

Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.

Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.

Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer

Giggles N' Hugs, Inc. Company Blog

Giggles N' Hugs, Inc. News:

Giggles Ní Hugs Announces Second Quarter 2015 Financial Results

Giggles Ní Hugs Advances Negotiations with largest National Mall Owners

Interest in Giggles Ní Hugs Franchise Opportunities Continues to Grow

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(CHIT)

2.

SmallCapVoice
(BWVI)

3.

Investor News Source
(CLWD)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251